Abstract
The development and introduction of recombinant factor VIII (rFVIII) concentrates nearly 20 years ago represented a major advance in the treatment of hemophilia A patients. Currently, first-, second- and third-generation rFVIII products are commercially available. Whereas first-generation rFVIII concentrates are stabilized with human albumin, second-generation rFVIII products contain sucrose instead of albumin in the final formulation. Finally, third-generation rFVIII products are manufactured without additional human or animal plasma proteins. The use of rFVIII concentrates has greatly improved the safety of replacement therapy in hemophilia A and virtually abolished the risk of blood-borne pathogen transmission. The remaining and most challenging aspect of hemophilia A management has now become the development of FVIII inhibitors. In this article we review the current knowledge on the commercially available rFVIII concentrates, analyzing their main characteristics. Moreover, results of the literature on their clinical hemostatic efficacy and safety are summarized.
Citations
Dec 14, 2011·Hematology·Patrick F Fogarty
May 4, 2012·Orphanet Journal of Rare Diseases·Massimo Franchini, Pier Mannuccio Mannucci
Apr 23, 2013·Italian Journal of Pediatrics·Paola GiordanoAngelo Claudio Molinari
May 9, 2012·Drugs·Sohita Dhillon
Jun 13, 2014·Blood Transfusion = Trasfusione Del Sangue·Antonio CoppolaGiovanni Di Minno
Nov 8, 2013·Journal of Thrombosis and Thrombolysis·Min XuanRenchi Yang
Mar 21, 2012·Expert Opinion on Biological Therapy·Emmanuel J FavaloroGiuseppe Lippi
May 19, 2011·Annals of Medicine·Giuseppe LippiEmmanuel J Favaloro
Jan 26, 2016·Acta Pharmacologica Sinica·Ruo-lan GuGui-fang Dou
Jun 4, 2015·Thrombosis Research·Stefan SchmidbauerStefan Schulte
Dec 4, 2015·Thrombosis and Haemostasis·H Marijke van den BergUNKNOWN PedNet Study group
Aug 15, 2015·Hämostaseologie·A TiedeJ Oldenburg
Jun 18, 2015·Scientific Reports·Daniela DalmSvetla Stoilova-McPhie
Nov 9, 2010·Air Medical Journal·Peter Tilney
Jul 10, 2014·Pediatric Hematology and Oncology·Paola GiordanoAntonio Coppola
Jul 9, 2013·Thrombosis Research·Sabine B ZollnerStefan Schulte
Feb 24, 2015·Journal of Pharmaceutical and Biomedical Analysis·Alfred WeberPeter L Turecek
Feb 23, 2020·Journal of Thrombosis and Haemostasis : JTH·Rosella FamàAntonia Follenzi